Clinical characteristics and prognosis of non-APAP drug-induced acute liver failure: a large multicenter cohort study.

[1]  R. Fontana,et al.  AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury , 2022, Hepatology.

[2]  Jing Xu,et al.  Prediction of biochemical nonresolution in patients with chronic drug‐induced liver injury: A large multicenter study , 2021, Hepatology.

[3]  J. Odin,et al.  Liver Transplantation for Acute Liver Injury in Asians Is More Likely Due to Herbal and Dietary Supplements , 2021, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  N. Chalasani,et al.  Eight‐Fold Increase in Dietary Supplement–Related Liver Failure Leading to Transplant Waitlisting Over the Last Quarter Century in the United States , 2021, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  W. Qureshi,et al.  N-acetylcysteine in non-acetaminophen-induced acute liver failure: a systematic review and meta-analysis of prospective studies , 2021, Przeglad gastroenterologiczny.

[6]  W. Kim,et al.  Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases , 2021, Hepatology.

[7]  S. Sarin,et al.  Standard-volume plasma-exchange improves outcomes in patients with acute liver failure - A Randomized Controlled Trial. , 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  William M. Lee,et al.  Clinical and neurological outcomes in acetaminophen-induced acute liver failure: a twenty-one-year multicenter cohort study. , 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  Ming Yan,et al.  Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. , 2019, Gastroenterology.

[10]  C. Stephens,et al.  Herbal and Dietary Supplement‐Induced Liver Injuries in the Spanish DILI Registry , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[11]  William M. Lee,et al.  Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy , 2018, Liver international : official journal of the International Association for the Study of the Liver.

[12]  William M. Lee,et al.  The Natural History of Severe Acute Liver Injury , 2017, The American Journal of Gastroenterology.

[13]  M. Manns,et al.  EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. , 2017, Journal of hepatology.

[14]  Tauseef Nabi,et al.  Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study , 2017, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[15]  Samar Kamal Darweesh,et al.  Effect of N-Acetylcysteine on Mortality and Liver Transplantation Rate in Non-Acetaminophen-Induced Acute Liver Failure: A Multicenter Study , 2017, Clinical Drug Investigation.

[16]  Valerie Durkalski,et al.  Development of a Model to Predict Transplant-free Survival of Patients With Acute Liver Failure. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  William M. Lee,et al.  Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury , 2016, The American Journal of Gastroenterology.

[18]  P. Angus,et al.  Resolution of norfloxacin-induced acute liver failure after N-acetylcysteine therapy: further support for the use of NAC in drug-induced ALF? , 2016, BMJ Case Reports.

[19]  W. Kim,et al.  Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites , 2015, Gut.

[20]  H. Barnhart,et al.  Liver injury from herbals and dietary supplements in the U.S. Drug‐Induced Liver Injury Network , 2014, Hepatology.

[21]  Philip Wong,et al.  Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver , 2014, Hepatology.

[22]  William M. Lee,et al.  ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury , 2014, The American Journal of Gastroenterology.

[23]  Baolin Wang,et al.  Causes and Outcomes of Acute Liver Failure in China , 2013, PloS one.

[24]  M. Mcphail,et al.  Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. , 2013, Journal of hepatology.

[25]  William M. Lee,et al.  Drug‐induced acute liver failure: Results of a U.S. multicenter, prospective study , 2010, Hepatology.

[26]  William M. Lee,et al.  Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. , 2009, Gastroenterology.

[27]  R. Andrade,et al.  Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. , 2005, Gastroenterology.

[28]  William M. Lee,et al.  AASLD Position Paper: The Management of Acute Liver Failure: Update 2011 , 2011 .

[29]  T. Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001 .

[30]  G. Danan,et al.  Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. , 1993, Journal of clinical epidemiology.

[31]  William M. Lee,et al.  HBV‐Associated Acute Liver Failure After Immunosuppression and Risk of Death , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[32]  J. Neuberger,et al.  Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. , 1997, Journal of hepatology.